Both in Pharmaceuticals
Relmada Therapeutics vs Rezolute, Inc. Common Stock (NV)
Over the past year RLMD returned +98.4% and RZLT returned −56.0%; their daily moves had a correlation of 0.11.
RLMD +98.4% RZLT −56.0%Growth of $1, one year, split-adjusted
| Metric | RLMD | RZLT |
|---|---|---|
| Price | $3.73 | $4.09 |
| Market cap | $397.9M | $395.6M |
| Today | −1.58% | −2.15% |
| 1 month | −13.9% | −11.5% |
| 6 months | −41.5% | +43.5% |
| Year to date | −22.8% | +73.3% |
| 1 year | +106.1% | −56.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $217.7M | $107.8M |
| Dividend yield | — | — |
| Volatility (60d) | 59.8% | 61.8% |
| Short % of float | 16.6% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).